Anika Therapeutics, Inc. (ANIK)
13.40
-0.41
(-2.97%)
USD |
NASDAQ |
Nov 13, 16:00
13.34
-0.06
(-0.41%)
After-Hours: 19:59
Anika Therapeutics Price to Book Value : 1.305 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 1.305 |
| November 12, 2026 | 1.344 |
| November 11, 2026 | 1.358 |
| November 10, 2026 | 1.311 |
| November 09, 2026 | 1.418 |
| November 06, 2026 | 1.416 |
| November 05, 2026 | 1.882 |
| November 04, 2026 | 1.986 |
| November 03, 2026 | 1.894 |
| November 02, 2026 | 1.890 |
| October 30, 2026 | 2.040 |
| October 29, 2026 | 2.121 |
| October 28, 2026 | 2.098 |
| October 27, 2026 | 2.079 |
| October 26, 2026 | 2.071 |
| October 23, 2026 | 2.085 |
| October 22, 2026 | 2.053 |
| October 21, 2026 | 2.006 |
| October 20, 2026 | 1.99 |
| October 19, 2026 | 1.968 |
| October 16, 2026 | 1.945 |
| October 15, 2026 | 2.014 |
| October 14, 2026 | 1.972 |
| October 13, 2026 | 1.999 |
| October 12, 2026 | 1.993 |
| Date | Value |
|---|---|
| October 09, 2026 | 1.906 |
| October 08, 2026 | 1.872 |
| October 07, 2026 | 1.901 |
| October 06, 2026 | 1.862 |
| October 05, 2026 | 1.921 |
| October 02, 2026 | 1.860 |
| October 01, 2026 | 1.885 |
| September 30, 2026 | 1.914 |
| September 29, 2026 | 1.944 |
| September 28, 2026 | 2.016 |
| September 25, 2026 | 1.986 |
| September 24, 2026 | 1.972 |
| September 23, 2026 | 1.986 |
| September 22, 2026 | 2.036 |
| September 21, 2026 | 2.018 |
| September 18, 2026 | 2.029 |
| September 17, 2026 | 2.050 |
| September 16, 2026 | 2.032 |
| September 15, 2026 | 2.038 |
| September 14, 2026 | 2.066 |
| September 11, 2026 | 2.034 |
| September 10, 2026 | 2.046 |
| September 09, 2026 | 2.036 |
| September 08, 2026 | 2.051 |
| September 04, 2026 | 2.029 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 0.3654 |
| MiMedx Group, Inc. | 2.219 |
| T2 Biosystems, Inc. | -- |
| ABVC BioPharma, Inc. | 1.872 |
| Intuitive Surgical, Inc. | 9.618 |
Price to Book Value Related Metrics
| PS Ratio | 1.501 |
| Price to Free Cash Flow | 80.73 |
| Price | 13.40 |
| Earnings Yield | -1.01% |
| Market Cap | 179.48M |